Aspen Neuroscience (ASPE) insider trading in the last 6 months

One insider bought $20M. No sales.

Quality Score3Below Average

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 3 tradesSee it live, free for 24 hours. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

BuyArch Venture Fund X, L.P.$18M10% ownerat $15.00 on Nov 2, filed Nov 2

BuyArch Venture Fund X, L.P.10% owner$18Mat $15.00 on Nov 2, filed Nov 2

BuyArch Venture Fund X, L.P.$1M10% ownerat $15.00 on Nov 2, filed Nov 2

BuyArch Venture Fund X, L.P.10% owner$1Mat $15.00 on Nov 2, filed Nov 2

BuyArch Venture Fund X, L.P.$1000K10% ownerat $15.00 on Nov 2, filed Nov 2

BuyArch Venture Fund X, L.P.10% owner$1000Kat $15.00 on Nov 2, filed Nov 2

From SEC Form 4s, the newest filed Nov 2, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on ASPE with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about ASPE's insider trades

As of Nov 10, 2026: Aspen Neuroscience (ASPE) has 3 insider filings on record in the last 6 months, the newest filed Nov 2, 2026. Its Quality Score is 3 (Below Average). Scores as of 10:45 AM ET, 15 minutes behind.

Are ASPE insiders buying or selling?

One insider bought $20M across 3 filings in the last 6 months. No open-⁠market sales on record. The newest filing: Arch Venture Fund X, L.P., 10% owner, bought $18M on Nov 2, 2026.

Who are ASPE's biggest insider sellers?

No ASPE insider sold shares on the open market in the last 6 months, as filed on Form 4.

When did an ASPE insider last buy?

Arch Venture Fund X, L.P., 10% owner, bought ASPE shares ($18M) on Nov 2, 2026, the newest insider buy on record.

Aspen Neuroscience's page has its Quality Score, its chart, and its earnings. More in Healthcare and Pharma. ASPE is on insider buys, Nov 2 to 8, 2026.

Aspen Neuroscience (ASPE) insider trading in the last 6 months

Form 4 filings, newest first

Questions about ASPE's insider trades

Every insider trade, with its stock's score.